Brief: Sonoma Pharmaceuticals Reports Third Quarter FY 2021 Financial Results
Feb 16 (Reuters) - Sonoma Pharmaceuticals Inc SNOA.O :
* SONOMA PHARMACEUTICALS REPORTS THIRD QUARTER FY 2021
FINANCIAL
RESULTS
* Q3 REVENUE ROSE 12 PERCENT TO $4.936 MILLION
* Q3 LOSS PER SHARE $0.32
Source text for Eikon: ID:nBw7zXSdRa
Further company coverage: SNOA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing